Data / Form D filings / Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc.: Form D filings
Olema Pharmaceuticals, Inc., a pharmaceuticals company in San Francisco, CA, filed 6 Form D notices with the SEC between 2018 and 2024. The latest, on December 12, 2024, reports $250 million sold of a $250 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 780 BRANNAN STREET, San Francisco, CA, 94103
- Phone
- (415) 651-3316
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1750284
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | New notice | $249,999,986 | $249,999,225 | $761 | 26 | Dec 4, 2024 | sec.gov |
| Sep 14, 2023 | New notice | $130,000,000 | $130,000,000 | 12 | Sep 5, 2023 | sec.gov | |
| Oct 13, 2020 | New notice | $87,437,914 | $87,437,914 | 27 | Sep 30, 2020 | sec.gov | |
| Jun 23, 2020 | Amendment | $55,400,000 | $53,900,000 | $1,500,000 | 16 | Mar 13, 2020 | sec.gov |
| Mar 27, 2020 | New notice | $45,000,000 | $30,000,000 | $15,000,000 | 11 | Mar 13, 2020 | sec.gov |
| Aug 27, 2018 | New notice | $6,054,922 | $6,054,922 | 13 | Jul 19, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David C. Myles, Ph.D. | Executive Officer | |
| Sandra L. Horning, M.D. | Director | |
| Scott L. Garland | Director | |
| Sean Bohen, M.D., Ph.D. | Executive Officer, Director | |
| Andrew C. Rappaport | Director | |
| Graham L. Walmsley, M.D., Ph.D. | Director | |
| Naseem C. Zojwalla, M.D. | Executive Officer | |
| Yi C. Larson | Director | |
| Cyrus L. Harmon, Ph.D. | Director | |
| Shane C. Kovacs | Executive Officer | |
| Ian L. Clark | Director | |
| Gorjan L. Hrustanovic, Ph.D. | Director | |
| Cynthia C. Butitta | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 9, 2024 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Olema Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.